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Figure 2: Prosthetic valve
implanted during TAVR4
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• Out of 26 conditions, only 3 of LVHN’s mortality rates were higher than
those of the STS/ACT registry and out of 23 conditions, 15 of LVHN’s
stroke rates were higher than those of the STS/ACT registry
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• The low percentage of pacemaker implantation indicates that the
patients often return to normal rhythm after surgery, which allows for
an easier recovery.
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Figure 3: A comparison of the LVHN and STS/ACC TVT Registry3
Mortality rates for the various patient conditions and comorbidities.

• The TF approach has overall better outcomes. This is most likely
because patients undergoing the TA approach often have coronary
artery disease.
•
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• Factors predicting success include an existing high volume of
interventional cardiology and cardiac surgical program, documented
quality outcomes, a hybrid operating room, and the ability for the
interventional cardiologists and cardiac surgeons to work as a
collaborative team.
• The limitation to this study includes the low number of patients so
there were some underrepresented demographics.
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Patients with less comorbidities, and therefore lower STS Prom %,
had overall better outcomes.

• These results confirm that TAVR procedures can be performed safely
at a tertiary academic community hospital with excellent outcomes.
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A retrospective chart review was performed. The TAVR procedure
was executed over the course of three years in patients with
severe aortic stenosis. These patients were deemed high-risk for
surgical aortic valve replacement during the TAVR clinic and were
therefore considered to be good candidates for the TAVR
procedure. Age, gender, comorbidities, patient mortality, stroke,
and pacemaker implantation were determined by reviewing the
patient records. All patients were evaluated to determine the
mortality and stroke rates. Only patients without pacemakers prior
to surgery were evaluated to determine the rate of pacemaker
implantation after surgery. The comparison data from the
PARTNER Trials was taken from the study, “Clinical Outcomes at 1
Year Following Transcather Aortic Valve Replacement.”3

A review of the first 3 years shows 225 TAVR procedures were
performed, 134 Trans-Femoral (TF), 91 Trans-Apical (TA). The
patient population was 120 men and 105 women, age ranging
from 50 to 99, 41 of whom were less than 75 years old, 96 were
75 to 84 years old, 81 were 85 to 94 years old, and 1 was greater
than 95 years old. The need for pacemaker was 41 (21.81%).
The 4 in-hospital deaths were due to stroke (1), liver failure (1),
cardiac failure (1), and hemorrhage (1).
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Figure 1: Prosthetic valves
implanted during surgical aortic
valve replacement 4

Severe Aortic Stenosis (AS) is the
narrowing or obstruction of the aortic
valve.1 Transcatheter aortic valve
replacement (TAVR) is a transformative
procedure that avoids the need for
conventional open-heart aortic valve
replacement in high-risk patients.2 TAVR
uses a sheath to implant the prosthetic
valve into the existing aortic valve. The
catheter is fed into either the groin
(transfemoral) or the chest (transapical)
and then guided through the blood
vessel into the aorta.3Although the
procedure is considered less invasive, it
has not yet been cleared for low-risk
patients. In order to be considered highrisk, the patient must have several
comorbities that prevent him or her for
being a viable candidate for surgical
aortic valve replacement.3
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Figure 4: A comparison of the LVHN and STS/ACC TVT
Stroke rates for the various patient conditions and comorbidities.
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